Jan Terje Andersen

Professor, Biomedical Innovation at University of Oslo and Oslo University Hospital

Speaker

Jan Terje Andersen is professor in biomedical innovation at University of Oslo, and a research group leader at Oslo University Hospital. He is heading the Laboratory of Adaptive Immunity and Homeostasis, which is a member of PRIMA – a Centre of Excellence in Precision Immunotherapy funded by the Research Council of Norway. His laboratory is studying the cellular processes and molecular interplay underlying the functions of the two most abundant proteins in blood, albumin and IgG. By combining structural and biophysical approaches with cellular and in vivo studies, the knowledge is used in design of novel molecules with improved functions. The laboratory is extensively collaborating with biotech and pharmaceutical companies. Andersen has obtained the Fridtjof Nansen Prize for Early Career Achievements and a Distinguished Innovator Grant from Novo Nordisk Foundation. He is an elected member of the Norwegian Academy of Science and Letters, and also a co-founder of the biotech companies Authera AS and Superio Bio AS.